INSIST! Acute Myeloid Leukemia
May 2026
Insist! on Better Care
Biomarker testing in Acute Myeloid Leukemia (AML) is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! AML is to educate and empower patients and care partners to speak up and insist on better care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding Testing in AML
When Is It Necessary to Repeat Key AML Tests?
May 27, 2026
INSIST! on Better Care: Why AML Testing Matters
May 13, 2026
Why AML Testing Matters Resource Guide
May 5, 2026
Self-Advocacy | Why In-Depth Cancer Testing Is Essential
December 5, 2025
Molecular Testing and Hereditary Testing: What’s the Difference?
December 5, 2025
When Should Someone With Cancer Undergo Molecular Testing?
November 6, 2025
What Is Molecular Testing and Why Is It Necessary in Cancer Care?
November 6, 2025
INSIST! AML Resource Guide | Testing
July 11, 2023
How Have Advances in Testing Impacted AML Care?
May 10, 2023
What Is the Purpose of AML Genetic Testing?
April 24, 2023
The Importance of Molecular Testing Following an AML Relapse
April 24, 2023
How Does the Presence of Molecular Markers Affect AML Care?
December 7, 2022
Diagnosing and Treating AML: What Testing Is Essential?
December 7, 2022
Which Tests Do You Need Before Deciding on an AML Treatment Path?
November 11, 2021
Understanding Key Tests That Affect AML Treatment Choices
August 25, 2021
What Key Tests Do You Need Before Choosing an AML Treatment?
August 12, 2021
How Molecular Testing Has Transformed AML Treatment Options
March 30, 2021
AML Treatment Decisions
Understanding MRD and Its Impact on AML Care
May 27, 2026
Emerging AML Treatment Classes Showing Promise
May 10, 2023
Low-Risk Versus High-Risk AML
May 10, 2023
Emerging AML Treatments: What Is Menin Inhibitor Therapy?
April 24, 2023
INSIST! on Better AML Care Resource Guide
December 13, 2022
Does Maintenance Therapy Have a Role in AML Care?
December 7, 2022
Advances in AML Research | Where Do Clinical Trials Fit In?
December 7, 2022
How Is AML Treatment Effectiveness Monitored?
August 25, 2021
Is the COVID-19 Vaccine Safe and Effective for AML Patients?
August 25, 2021
How to Be a Partner in Your AML Care
August 25, 2021
What Is Low-Intensity AML Therapy?
August 25, 2021
Factors to Consider When Choosing an AML Treatment
August 25, 2021
Understanding Personalized Medicine for AML
August 25, 2021
This program is supported by AbbVie, Astellas, Bristol Myers Sqibb/Celgene, Daiichi-Sankyo, Foundation Medicine, Jazz, Novartis, and through generous donations from people like you.